CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...